Phase 2 Multicenter Trial of ICOS Agonist Monoclonal Antibody (mAb)
JTX-2011 and a CTLA-4 inhibitor in PD-1/PD-L1 Inhibitor Experienced
Adult Subjects with Non-small Cell Lung Cancer or Urothelial Cancer

IRB/UVA Tracking #
21811
Contact
Gracie Hockenberry
Contact Email
Contact Phone
1.434.297.7784
Phase
II
Primary purpose
Treatment
Cancer PI
Ryan Gentzler
Status
OPEN TO ACCRUAL
Ages
Adult